booom!! what been waiting for. great work NOX. commerical deals in USA on the horizon.
U.S. Food and
Drug Administration (FDA) has approved the Investigational New Drug (IND) application for
Veyonda® for combination treatment with doxorubicin in patients with soft tissue sarcomas.
FDA for being a safe and well-tolerated drug.”
Ann: FDA grants IND approval to Veyonda, page-2
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.001(1.22%) |
Mkt cap ! $24.25M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.4¢ | 8.2¢ | $18.91K | 229.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13194 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 15.37pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
8.3¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 8.3¢ | 8.4¢ | 8.3¢ | 40250 | ||
| Last updated 15.37pm 07/06/2024 ? | |||||
| NOX (ASX) Chart |